Alan J. Tiefenbrunn - Concepedia

Author

Alan J. Tiefenbrunn

Also Known As

A J Tiefenbrunn, A. J. Tiefenbrunn, A.J. Tiefenbrunn, ALAN J. TIEFENBRUNN, ALAN TIEFENBRUNN, Alan J Tiefenbrunn, Alan J. Tiefenbrunn, Alan J. Tiefenbrunn Facc, Alan Tiefenbrunn

Publications

4.8K

Citations

H-Index

Concepts

All Affiliations

Washington University in St. Louis University of Alabama University of Massachusetts Chan Medical School University of California, San Francisco UCLA Medical Center

About

Alan J. Tiefenbrunn is an author at Washington University in St. Louis specializing in cardiovascular disease, medicine, and cardiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	24	26	2.8K
2	Public Health	12	12	1.5K
3	Biomedical Engineering	4	4	548
4	Health Sciences	3	3	146
5	Engineering	1	1	94

Alan J. Tiefenbrunn

Publications

4.7K

Citations

H-Index

Page 1

	Year	Citations
Temporal trends in the treatment of over 1.5 million patients with myocardial infarction in the U.S. from 1990 through 1999 William J. Rogers, John G. Canto, Costas T. Lambrew, Journal of the American College of Cardiology Percutaneous Coronary InterventionCardiovascular DiseaseHealth PolicyTemporal TrendsCoronary Unit	2000	658
Treatment of myocardial infarction in the United States (1990 to 1993). Observations from the National Registry of Myocardial Infarction. William J. Rogers, Laura J. Bowlby, Nisha C. Chandra, Circulation	1994	476
Coronary thrombolysis with recombinant human tissue-type plasminogen activator: a prospective, randomized, placebo-controlled trial. D Collen, Eric J. Topol, Alan J. Tiefenbrunn, Circulation Fibrinogen LevelPlacebo-controlled TrialCoronary Artery DiseaseAcute Myocardial InfarctionThrombosis	1984	385
The Volume of Primary Angioplasty Procedures and Survival after Acute Myocardial Infarction John G. Canto, Nathan R. Every, David J. Magid, New England Journal of Medicine	2000	379
Coronary Thrombolysis with Tissue-Type Plasminogen Activator in Patients with Evolving Myocardial Infarction Frans Van de Werf, Philip A. Ludbrook, Steven R. Bergmann, New England Journal of Medicine PharmacotherapyBiomedical EngineeringCoronary Artery DiseaseAcute Myocardial InfarctionThrombosis	1984	361
Use of Reperfusion Therapy for Acute Myocardial Infarction in the United States Hal V. Barron, Laura J. Bowlby, Tim Breen, Circulation	1998	317
Trends in reperfusion strategies, door-to-needle and door-to-balloon times, and in-hospital mortality among patients with ST-segment elevation myocardial infarction enrolled in the National Registry of Myocardial Infarction from 1990 to 2006 C. Michael Gibson, Yuri B. Pride, Charles V. Pollack, American Heart Journal ThrombosisCardiovascular DiseaseMyocardial InfarctionPatient SafetyNational Registry	2008	280
Number of Coronary Heart Disease Risk Factors and Mortality in Patients With First Myocardial Infarction John G. Canto, Catarina I. Kiefe, William J. Rogers, JAMA	2011	256
Clinical Experience With Primary Percutaneous Transluminal Coronary Angioplasty Compared With Alteplase (Recombinant Tissue-Type Plasminogen Activator) in Patients With Acute Myocardial Infarction Alan J. Tiefenbrunn, Nisha C. Chandra, William J. French, Journal of the American College of Cardiology	1998	214
Acute hemodynamic responses to sublingual nifedipine: dependence on left ventricular function. P A Ludbrook, Alan J. Tiefenbrunn, F R Reed, Circulation	1982	140

Page 1